Open source all-atom model of entire COVID-19 S protein released
Researchers have developed a video and model-building programme for other scientists to build full-length COVID-19 S protein models.
An international group of researchers has released the first open-source all-atom models of a full-length Spike (S) protein, which the SARS-CoV-2 virus uses to enter human cells and cause COVID-19. The researchers say this protein is of particular importance as a vaccine and antiviral drug development target.
The team was made up of researchers from Seoul National University in South Korea, University of Cambridge in the UK and Lehigh University in the US.
The graphical user interface the researchers used is a programme that simulates complex biomolecular systems simply, precisely and quickly. It enables scientists to understand molecular-level interactions that cannot be observed any other way.
The S protein structure was determined using cryo-EM with the receptor binding domain (RBD) up and with the RBD down. However, the researchers say this model had many missing residues. So, they first modelled the missing amino acid residues and then other missing domains. In addition, they modelled all potential glycans attached to the S protein. These glycans prevent antibody recognition, which makes it difficult to develop a vaccine. They also built a viral membrane system of an S protein for molecular dynamics simulation.
“Our models are the first fully-glycosylated full-length SARS-CoV-2 S protein models that are available to other scientists,” said Professor Wonpil Im, at Lehigh University’s Department of Biological Sciences and Bioengineering Department. “Our team spent days and nights to build these models very carefully from the known cryo-electron microscopy (cryo-EM) structure portions. Modelling was very challenging because there were many regions where simple modelling failed to provide high-quality models.”
According to the researchers, scientists can use the models to conduct innovative and novel simulation research for the prevention and treatment of COVID-19.
Professor Wonpil Im